Proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR), and
neovascular age-related macular degeneration (nAMD) are among the leading causes of …

Type 2 diabetes mellitus (T2DM) still holds the title as one of the most debilitating chronic
diseases with rising prevalence and incidence, including its complications such as retinal …

Background Intravitreal injection of anti-vascular endothelial growth factor (VEGF) has
become first line therapy for diabetic macular edema. This study evaluated the efficacy and …

Diabetic retinopathy (DR) is the most frequent microvascular retinal complication of diabetic
patients, contributing to loss of vision. Recently, retinal neuroinflammation and …

Momordica charantia polysaccharide (MCP) is a potential drug for the prevention and
alleviation of diabetes mellitus (DM) and diabetic retinopathy (DR). This study aimed to …

Metabolomics is the analysis of numerous small molecules known as metabolites. Over the
past few years, with the continuous development in metabolomics, it has been widely used …

Diabetic eye disease is a major cause of blindness worldwide. The ability to monitor relevant
clinical trajectories and detect lapses in care is critical to managing the disease and …

Background: Worldwide, retinopathy, nephropathy, and neuropathy are the major diabetes-
related microvascular complications. In Palestine, a low-middle-income country, diabetes is …

Objective The endometrial cancer is a disorder with elevated oxidative stress. The high
oxidative stress resulting from hyperglycemia can lead to diabetic retinopathy (DR) …

Introduction: Diabetes is a pandemic disease that causes relevant ocular pathologies.
Diabetic retinopathy, macular edema, cataracts, glaucoma, or keratopathy strongly impact …